TY - JOUR
T1 - The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency
AU - Schreiber, S.
AU - Getslev, V.
AU - Backer, M. M.
AU - Weizman, R.
AU - Pick, C. G.
N1 - Funding Information:
This work was supported in part by the Tel Aviv University Foundation for Basic research and by the N. Horowitz Fund of the Tel Aviv University.
PY - 1999/9
Y1 - 1999/9
N2 - Using the mouse tail-flick assay, we evaluated the antinociceptive effect and the interaction with the opioid, adrenergic, and serotonergic systems of the two 'atypical' neuroleptic agents clozapine and olanzapine. Clozapine induced a potent antinociceptive effect in a dose-dependent manner with ED50 of 8.7 mg/kg. This effect was antagonized by the nonselective opioid antagonist naloxone (p < 0.05), implying an opioid mechanism of action involved in clozapine-induced antinociception. Further evaluation demonstrated the involvement of μ1-, μ2-, κ1- opioid receptor subtypes and of α2-adrenoreceptors in clozapine antinociception but not the serotonin receptors. Olanzapine induced a weak antinociceptive effect. The highest effect found was a 50% antinociception following an injection of 10 mg/kg. As the olanzapine dose increased beyond 10 mg/kg, latencies declined almost back to baseline. Yohimbine (an α2-adrenoreceptor antagonist) significantly reduced olanzapine's antinociceptive effect almost completely (to 10%; p < 0.05), while both naloxone and metergoline (a nonselective 5-HT receptor antagonist) reduced it only partially. These results indicate the possible involvement of the α2-adrenoreceptors in olanzapine antinociception and to a less extent the involvement of opioid and serotonergic receptors. Although both clozapine and olanzapine are dibenzodiazepines with similar 'atypical' antipsychotic properties, it seems that they differ notably not only regarding their hematological side effects, but regarding their interaction with the opioid system as well. Copyright (C) 1999 Elsevier Science Inc.
AB - Using the mouse tail-flick assay, we evaluated the antinociceptive effect and the interaction with the opioid, adrenergic, and serotonergic systems of the two 'atypical' neuroleptic agents clozapine and olanzapine. Clozapine induced a potent antinociceptive effect in a dose-dependent manner with ED50 of 8.7 mg/kg. This effect was antagonized by the nonselective opioid antagonist naloxone (p < 0.05), implying an opioid mechanism of action involved in clozapine-induced antinociception. Further evaluation demonstrated the involvement of μ1-, μ2-, κ1- opioid receptor subtypes and of α2-adrenoreceptors in clozapine antinociception but not the serotonin receptors. Olanzapine induced a weak antinociceptive effect. The highest effect found was a 50% antinociception following an injection of 10 mg/kg. As the olanzapine dose increased beyond 10 mg/kg, latencies declined almost back to baseline. Yohimbine (an α2-adrenoreceptor antagonist) significantly reduced olanzapine's antinociceptive effect almost completely (to 10%; p < 0.05), while both naloxone and metergoline (a nonselective 5-HT receptor antagonist) reduced it only partially. These results indicate the possible involvement of the α2-adrenoreceptors in olanzapine antinociception and to a less extent the involvement of opioid and serotonergic receptors. Although both clozapine and olanzapine are dibenzodiazepines with similar 'atypical' antipsychotic properties, it seems that they differ notably not only regarding their hematological side effects, but regarding their interaction with the opioid system as well. Copyright (C) 1999 Elsevier Science Inc.
KW - Antinociceptive effect
KW - Atypical neuroleptic
KW - Clozapine
KW - Mouse tail-flick assay
KW - Olanzapine
KW - Pain
UR - http://www.scopus.com/inward/record.url?scp=0032885115&partnerID=8YFLogxK
U2 - 10.1016/S0091-3057(99)00107-0
DO - 10.1016/S0091-3057(99)00107-0
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0032885115
SN - 0091-3057
VL - 64
SP - 75
EP - 80
JO - Pharmacology Biochemistry and Behavior
JF - Pharmacology Biochemistry and Behavior
IS - 1
ER -